[1]
“DESIGN DEVELOPMENT AND CHARACTERIZATION OF OMEPRAZOLE LOADED NANOSUSPENSION”, Journal of Pharmaceutical Negative Results, pp. 1195–1208, Nov. 2022, doi: 10.47750/pnr.2022.13.S08.149.